David V. Smith

2018

In 2018, David V. Smith earned a total compensation of $2M as Executive Vice President and Chief Financial Officer at Five Prime Therapeutics.

Compensation breakdown

Option Awards$1,474,432
Salary$44,103
Stock Awards$498,800
Other$1,075
Total$2,018,409

Smith received $1.5M in option awards, accounting for 73% of the total pay in 2018.

Smith also received $44.1K in salary, $498.8K in stock awards and $1.1K in other compensation.

Rankings

In 2018, David V. Smith's compensation ranked 5,707th out of 14,244 executives tracked by ExecPay. In other words, Smith earned more than 59.9% of executives.

ClassificationRankingPercentile
All
5,707
out of 14,244
60th
Division
Manufacturing
2,158
out of 5,765
63rd
Major group
Chemicals And Allied Products
799
out of 2,128
63rd
Industry group
Drugs
667
out of 1,817
63rd
Industry
Pharmaceutical Preparations
516
out of 1,391
63rd

Pay ratio

David V. Smith's Pay$2,018,409
Median Employee's Pay$201,670
Pay Ratio

10

to 1

In 2018, the annual total compensation of David V. Smith was $2,018,409.

The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.

The ratio of David V. Smith's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 29, 2019.

Smith's colleagues

We found six more compensation records of executives who worked with David V. Smith at Five Prime Therapeutics in 2018.

2018

Aron Knickerbocker

Five Prime Therapeutics

Chief Executive Officer

2018

Bryan Irving

Five Prime Therapeutics

Chief Scientific Officer

2018

Helen Collins

Five Prime Therapeutics

Chief Medical Officer

2018

Francis Sarena

Five Prime Therapeutics

Secretary

2018

Linda Rubinstein

Five Prime Therapeutics

Chief Financial Officer

2018

Marc Belsky

Five Prime Therapeutics

Chief Financial Officer

News

In-depth

You may also like